Showing results (221-230 of 359) with videos related to

Sort By:
Pageof 36
Hereditas|March 17, 2007
Principal component analysis of quantitative trait loci for immune response to adenovirus in miceSolomon K Musani, Huang-Ge Zhang, Hui-Chen Hsu, et al.
The Journal of Pharmacy and Pharmacology|October 30, 2008
Pharmacokinetics and pharmacodynamics of Phor21-betaCG(ala), a lytic peptide conjugateLee Jia, Patricia E Noker, Gary A Piazza, et al.
Clinical Science (London, England : 1979)|May 1, 1987
Gliadin binding to rat and human enterocytesJ Colyer, P J Kumar, N M Waldron, et al.
Gut|January 1, 1974
Amino acid and peptide absorption in patients with coeliac disease and dermatitis herpetiformisD B Silk, P J Kumar, D Perrett, et al.
Gut|April 1, 1973
Treatment of dermatitis herpetiformis with corticosteroids and a gluten-free diet: a study of jejunal morphology and functionP J Kumar, D B Silk, R Marks, et al.
Archives of Disease in Childhood|August 1, 1988
The teenage coeliac: follow up study of 102 patientsP J Kumar, J Walker-Smith, P Milla, et al.
Neuromuscular Disorders : NMD|May 6, 2014
Distal weakness with respiratory insufficiency caused by the m.8344A > G "MERRF" mutationEmma L Blakely, Charlotte L Alston, Bryan Lecky, et al.
Reproductive Toxicology (Elmsford, N.Y.)|September 6, 2011
Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeysShu-Ching Chang, Patricia E Noker, Gregory S Gorman, et al.
Toxicology Letters|March 6, 2012
Distribution of perfluorooctanesulfonate and perfluorooctanoate into human plasma lipoprotein fractionsJohn L Butenhoff, Elsbeth Pieterman, David J Ehresman, et al.
Toxicology|December 9, 2008
A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humansGeary W Olsen, Shu-Ching Chang, Patricia E Noker, et al.
Pageof 36